Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-041438·Ikarian Capital, LLC
Schedule 13G ownership disclosure
QUOIN PHARMACEUTICALS LTD
American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share · CUSIP: 74907L409
Event date: 2026-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ikarian Capital, LLC
Shares: 211,538 · Class: 12.6%
- Neil Shahrestani
Shares: 211,538 · Class: 12.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-041438
- Form type
- SCHEDULE 13G/A
- Filer
- Ikarian Capital, LLC
- CIK
- CIK 1778253
- Filed
- Feb 06, 2026
- Reporting period
- Jan 31, 2026
- Description
- Schedule 13G beneficial ownership